Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...

Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.

Brain Tumor Organoids Accurately Model Patient Response to CAR T Cell Therapy Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM ...

Jan. 28, 2025 — The latest findings on the interaction between cell death and cellular senescence in cancer and their pathophysiological significance have been ... Keeping the Steps of Cell ...

For example, a 5/1 ARM will have the same rate for the first five years, then can adjust each year after that—meaning the rate might go up or down, based on the market. An ARM isn’t for everyone.

Given the recent surge in Arm Holdings shares, we evaluate the stock's current position to determine whether it presents a good investment opportunity. Aspirational CPU manufacturer Arm Holdings ...

It feels like the Splinter Cell remake has been on its way for a while now, which isn't helped by the fact it's been over three years since we heard anything official about the game. From what we ...

We expect Arm will keep gaining market share in the data center from x86 architecture, as its chips consume less power and data centers need to minimize energy consumption. We also expect share ...

Cell growth usually refers to cell proliferation ... explore a selective vulnerability in cancer elicited by targeting aldolase A, which causes energy imbalance and prevents further metabolic ...

Cell signalling is the mechanism by which stimuli ... enhanced autophagy and liver tumor growth. Damaged lysosomes are eliminated by lysophagy, yet the regulatory mechanisms of this process ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...